Koyfin Home > Directory > Health Care > Acorda Therapeutics > Repurchase of Common Stock

Acorda Therapeutics Repurchase of Common Stock Chart (ACOR)

Acorda Therapeutics annual/quarterly Repurchase of Common Stock from 2010 to 2019.
  • Acorda Therapeutics Repurchase of Common Stock for the quarter ending December 12, 2019 was $0m a 0.00% increase of 0m year over year
  • Acorda Therapeutics Repurchase of Common Stock for the last 12 months ending June 06, 2020 was $0m a 0.00% increase of 0m year over year
  • Acorda Therapeutics Annual Repurchase of Common Stock for 2019 was $0m a -1,816.48% increase of 2m from 2018
  • Acorda Therapeutics Annual Repurchase of Common Stock for 2018 was $-2m a 96.56% decrease of -2m from 2017
  • Acorda Therapeutics Annual Repurchase of Common Stock for 2017 was $0m a -448.33% increase of 0m from 2016
Other Cash Flow Metrics:
  • Acorda Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $78m a 23.00% increase of 18m year over year
  • Acorda Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $60m a 1.90% increase of 1m year over year
  • Acorda Therapeutics Total Revenue for the quarter ending December 12, 2018 was $69m a -53.52% decrease of -37m year over year
View Chart On Koyfin

Quarterly ACOR Repurchase of Common Stock Data

12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$-1m
12/2017$0m
09/2017$0m

Annual ACOR Repurchase of Common Stock Data

2019$0m
2018$-2m
2017$0m
2010$0m